Health Condition 1: E039- Hypothyroidism, unspecified
Conditions
Interventions
Intervention1: Asgand and Brahmi: Asgand and Brahmi 6 gms powder twice daily orally with water after meals.
Control Intervention1: Levothyroxine: 50 mcg 2 tablets once daily orally with water before m
Sponsors
National Research Institute of Unani Medicine for Skin Disorders Hyderabad
Eligibility
Inclusion criteria
Inclusion criteria: Patients of any gender Patients in the age group between 19 and 60 years Patients with Symptomatic Subclinical Primary Hypothyroidism Patients with Clinical Primary Hypothyroidism TSH ranging 5-10mg/dl
Exclusion criteria
Exclusion criteria: Patients aged 60 years Asymptomatic cases of Subclinical Primary Hypothyroidism Severe/ complicated cases of Clinical Primary Hypothyroidism Patients with Drug-induced Hypothyroidism Patients on radiotherapy for head and neck region ï?· Patients who have undergone thyroidectomy ï?· Pregnant or Lactating Women ï?· Significant Pulmonary/ Cardiovascular/ Hepatic/ Renal Diseases ï?· Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies ï?· Patients with Diabetes Mellitus ï?· Patients with history of hypersensitivity to Asgand or Brahmi ï?· Patient not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical assessment will be done at 0, 2, 4 ,6 and 8 weeks and the response to treatment will be assessed using the following parameters: 1. Decrease in serum TSH level 2. Increase in serum Free T4 level 3. Improvement in the symptoms & signs of hypothyroidism as assessed by reduction in Zulewskiâ??s clinical score after treatmentTimepoint: 2nd week 4th week 6th week 8th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Lab investigationTimepoint: 0 and 8 weeks | — |
Countries
India
Contacts
Public Contactjuveria jabeen
National Research Institute of Unani Medicine for Skin Disorders
Outcome results
None listed